🔬

Cell Therapy

Cell-based treatments including CAR-T, TCR therapies, stem cell therapies, and allogeneic cell platforms.

Companies

Pipeline Drugs

Key People

Cell Therapy Pipeline (39 drugs)

Commercial: 9Research: 6Preclinical: 5Platform/Service: 5Approved: 4Service: 2Development: 2Clinical Development: 1Service/Diagnostic: 1Development/Validation: 1Clinical: 1Unknown: 1Phase 1/2: 1

Drug	Company	Indication	Phase	Status
KetoAir™ Breathalyzer	Avalon GloboCare	Ketosis Monitoring	Commercial	Marketed
QTY Code Platform	Avalon GloboCare	Cytokine Receptor Research/Therapeutic Discovery	Preclinical	Platform Validation
CHS™ Coated Stent	Corline Biomedical	Neurovascular/Peripheral Vascular Disease	Commercial	Partner-Driven
CHS™ Coated Ablation Catheter	Corline Biomedical	Cardiac Arrhythmia	Commercial	Partner-Driven
Renaparin®	Corline Biomedical	Kidney Transplantation	Clinical Development	Partnering
Cytoparin™	Corline Biomedical	Cell Therapy / Diabetes Type 1	Research	Partnering
CHC™	Corline Biomedical	Soft Tissue Repair	Research	Platform Expansion
Osmolex ER	bioRASI	Parkinson's Disease; Drug-induced extrapyramidal reactions	Approved	Commercial
ASD Diagnosis Aid	bioRASI	Diagnosis of Autism Spectrum Disorder (ASD) in pediatric patients	Approved	Commercial
Empaveli (pegcetacoplan)	bioRASI	Paroxysmal Nocturnal Hemoglobinuria (PNH)	Approved	Commercial
KSC Counting Platform Technology	Asymmetrex	Stem Cell Quantification for Multiple Applications	Platform/Service	Commercial/Development
AlphaSTEM Test®	Asymmetrex	Evaluation of Stem Cell Toxicity in Drug Development	Service/Diagnostic	Available
Stem Cell Dose Monitoring	Asymmetrex	Stem Cell Transplantation & Therapy	Service	Available
Tissue Stem Cell Counting Services	Asymmetrex	Research & Development Applications	Service	Available
Cell & Gene Therapy Synthetic Promoters	Chromatin Bioscience	Cell-selective gene expression for therapeutic systems	Platform/Service	Active R&D and Client Services
Biologics Manufacturing Promoters	Chromatin Bioscience	Increased protein yield in bioproduction	Platform/Service	Active R&D and Client Services
Industrial Biotechnology Promoters	Chromatin Bioscience	Metabolic engineering in chassis organisms	Platform/Service	Active R&D and Client Services
Agricultural Biotechnology Promoters	Chromatin Bioscience	Trait expression in crops (tissue-specific, stress-responsive)	Platform/Service	Active R&D and Client Services
Stempeucel®	Stempeutics Research	Knee Osteoarthritis	Commercial	Approved
Trichosera®	Stempeutics Research	Hair Growth	Commercial	Approved
Cutisera®	Stempeutics Research	Skin Rejuvenation	Commercial	Approved
Perioptisera®	Stempeutics Research	Under‑eye Dark Circle Treatment	Commercial	Approved
Human Liver Models	Tempo Bioscience	Toxicity Evaluation & Disease Modeling	Development	Active
Blood-Brain-Barrier (BBB) Models	Tempo Bioscience	CNS Drug Development	Development	Active
Synova WAVE System	Synova Life Sciences	Processing of adipose tissue for autologous transplantation	Approved	Active
TxPredictor for Transplant Medicine	Pirche	Donor-Recipient Matching & Immune Risk Assessment (Solid-organ & Bone Marrow)	Commercial	Active
TxPredictor for Cell Therapy	Pirche	Donor Selection for Allogeneic Cell Therapies	Development/Validation	Active
CaseCryo® CTG DMSO	CaseBioscience	Cell therapy cryopreservation	Clinical	Active
CaseCryo® DMSO 10%	CaseBioscience	Research‑grade cryopreservation	Research	Active
CaseCryo® NON-DMSO	CaseBioscience	Low‑toxicity cryopreservation	Research	Active
CaseBase® Washing Medium	CaseBioscience	Cell washing and processing	Research	Active
CaseBase® Dissociation Medium	CaseBioscience	Cell dissociation for culture	Research	Active
Linea 1	LineaBio	iPSC line for cell‑therapy manufacturing	Unknown	Available
Cultivated Human Red Blood Cells	Accellta	Blood product manufacturing	Preclinical	Active
Cultured Milk Fat	Accellta	Sustainable dairy ingredient	Preclinical	Active
Cultured Lobster Meat	Accellta	Alternative seafood protein	Preclinical	Active
Cultivated Chicken Paste	Esco Aster	Food / Alternative Protein	Commercial	Active
Engineered Cancer Exosomes (HLA‑G Targeted)	Esco Aster	Cancer Immunotherapy	Preclinical	Active
Induced Retinal Pigment Epithelium (RPE) Cells	Esco Aster	Dry Age‑Related Macular Degeneration	Phase 1/2	Active